Synthetic peptide corresponding to residues in Human TGF beta 1. (Uniprot: P01137)
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab124894 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Predicted molecular weight: 44, 48 kDa.Can be blocked with Human TGF beta 1 + 2 peptide (ab229618).|
ab124894 has not yet been referenced specifically in any publications.